Metformin Ratiopharm

Metformin, the active ingredient in Metformin Ratiopharm, is a Biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adults. GNH USA supplies Metformin Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is a biguanide antidiabetic that improves glucose control in several metabolic conditions. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Prediabetes: helps delay progression to overt diabetes by improving insulin sensitivity. - Metabolic syndrome: contributes to weight management and glycaemic regulation as part of a comprehensive lifestyle program.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools, especially during dose titration. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: life‑threatening accumulation of lactate, especially in renal impairment. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: rare liver enzyme elevations. - Hypoglycaemia: when combined with insulin or secretagogues. - Acute pancreatitis: very uncommon but reported. - Anemia: due to B12 deficiency with prolonged therapy.

Metformin requires careful assessment of patient factors before initiation. - Renal function: evaluate eGFR and avoid use if severely reduced. - Hepatic disease: contraindicated in severe liver impairment. - Alcohol consumption: limit intake to reduce lactic acidosis risk. - Pregnancy: prescribe only if potential benefit outweighs risk. - Elderly patients: start with lower dose and monitor tolerance. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformin may interact with several medicines, necessitating monitoring.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure. - Cimetidine: may increase metformin plasma concentrations. - Chronic alcohol abuse: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: affect renal clearance and electrolyte balance. - ACE inhibitors or ARBs: require renal function monitoring. - NSAIDs: may impair renal function, increasing metformin exposure. - Sulfonylureas: increase risk of hypoglycaemia when combined.